[
  {
    "ts": "2026-01-13T20:30:24+00:00",
    "headline": "JPM26: ThermoFisher ‘very positive’ on strategic M&A as deals expand capabilities",
    "summary": "ThermoFisher expects revenue growth in the 3–6% range for 2026 and 2027, and a growth rate of 7% or more in 2028 and beyond.",
    "url": "https://www.pharmaceutical-technology.com/analyst-comment/jpm26-thermofisher-very-positive-on-strategic-ma-as-deals-expand-capabilities/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "22519448-5757-3ef8-bce3-2030e24a0965",
      "content": {
        "id": "22519448-5757-3ef8-bce3-2030e24a0965",
        "contentType": "STORY",
        "title": "JPM26: ThermoFisher ‘very positive’ on strategic M&A as deals expand capabilities",
        "description": "",
        "summary": "ThermoFisher expects revenue growth in the 3–6% range for 2026 and 2027, and a growth rate of 7% or more in 2028 and beyond.",
        "pubDate": "2026-01-13T20:30:24Z",
        "displayTime": "2026-01-13T20:30:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/98c0159b3586889403b6e5a7fb411166",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "The partnership between Thermo Fisher and Syncell is expected to result in ‘fully integrated’ spatial proteomics workflows. Image credit: JHVEPhoto via Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iKvJFiLnpUmqFN70.7lA5A--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/98c0159b3586889403b6e5a7fb411166.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k7VjFXH59ZomN3CaptE5Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/98c0159b3586889403b6e5a7fb411166.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/analyst-comment/jpm26-thermofisher-very-positive-on-strategic-ma-as-deals-expand-capabilities/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-thermofisher-very-positive-strategic-203024901.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "SOLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]